Read the press release in: English | Arabic
On 12 September 2020, the Minister of Health announced the start of clinical trials of COVID-19 vaccines in Egypt. This announcement was made three weeks after the Parliament approved the amended version of the Clinical Trials Law, which was introduced in response to the recommendations made by the President in October 2018.
And because monitoring clinical trial procedures in general, and this important experiment in particular, is part of the role of civil society, a member of the EIPR team volunteered and joined this clinical trial. He followed the procedures and was registered among the trial participants after completing and fulfilling the conditions for participation.